Novo Nordisk Pharmatech has announced it will be returning for the annual World Vaccine Congress.

2017 will be the 17th year World Vaccine Congress has run. Held in Washington D.C. from 10 April until 12 April, Novo Nordisk Pharmatech will be present at booth #54.

The company would like to invite you to visit the booth and discover more about recombinant insulin for innovative biologics and pharmaceutical grade Quaternary ammonium compounds.

Novo Nordisk remains one of the best suppliers of insulin for cell culture processes through excellence at every step of the supply chain, and the company has more than 65 years’ experience in the biopharmaceutical and pharmaceutical industries.

Novo Nordisk delivers a proven record of product purity, reliability, and consistency, creating high-quality products for future therapies.